<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p42" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_42{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_42{left:341px;bottom:30px;}
#t3_42{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_42{left:377px;bottom:30px;}
#t5_42{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_42{left:540px;bottom:30px;}
#t7_42{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_42{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_42{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_42{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_42{left:285px;bottom:827px;letter-spacing:-0.24px;}
#tc_42{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_42{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_42{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_42{left:1111px;bottom:28px;letter-spacing:0.1px;}
#tg_42{left:36px;bottom:236px;}
#th_42{left:42px;bottom:231px;letter-spacing:0.12px;}
#ti_42{left:342px;bottom:231px;letter-spacing:0.14px;}
#tj_42{left:447px;bottom:231px;}
#tk_42{left:36px;bottom:221px;}
#tl_42{left:42px;bottom:215px;letter-spacing:0.1px;word-spacing:-0.04px;}
#tm_42{left:325px;bottom:215px;}
#tn_42{left:36px;bottom:206px;}
#to_42{left:45px;bottom:200px;letter-spacing:0.13px;}
#tp_42{left:260px;bottom:200px;}
#tq_42{left:36px;bottom:191px;}
#tr_42{left:42px;bottom:185px;letter-spacing:0.12px;}
#ts_42{left:45px;bottom:169px;letter-spacing:0.1px;word-spacing:0.02px;}
#tt_42{left:45px;bottom:154px;letter-spacing:0.12px;}
#tu_42{left:45px;bottom:139px;letter-spacing:0.12px;}
#tv_42{left:114px;bottom:139px;letter-spacing:0.13px;}
#tw_42{left:198px;bottom:139px;}
#tx_42{left:36px;bottom:130px;}
#ty_42{left:50px;bottom:124px;letter-spacing:0.13px;word-spacing:-0.04px;}
#tz_42{left:45px;bottom:108px;letter-spacing:0.03px;}
#t10_42{left:109px;bottom:108px;}
#t11_42{left:36px;bottom:778px;letter-spacing:0.34px;word-spacing:-0.16px;}
#t12_42{left:275px;bottom:778px;letter-spacing:0.32px;word-spacing:-0.31px;}
#t13_42{left:832px;bottom:778px;letter-spacing:0.29px;}
#t14_42{left:832px;bottom:760px;letter-spacing:0.3px;}
#t15_42{left:1057px;bottom:778px;letter-spacing:0.34px;}
#t16_42{left:36px;bottom:684px;letter-spacing:-0.1px;}
#t17_42{left:36px;bottom:585px;letter-spacing:-0.1px;}
#t18_42{left:36px;bottom:566px;letter-spacing:-0.08px;}
#t19_42{left:36px;bottom:548px;letter-spacing:-0.09px;}
#t1a_42{left:36px;bottom:530px;letter-spacing:-0.09px;}
#t1b_42{left:36px;bottom:511px;letter-spacing:-0.09px;}
#t1c_42{left:36px;bottom:493px;letter-spacing:-0.09px;}
#t1d_42{left:36px;bottom:475px;letter-spacing:-0.09px;}
#t1e_42{left:140px;bottom:482px;}
#t1f_42{left:279px;bottom:704px;letter-spacing:-0.1px;}
#t1g_42{left:279px;bottom:686px;letter-spacing:-0.1px;}
#t1h_42{left:279px;bottom:667px;letter-spacing:-0.13px;}
#t1i_42{left:303px;bottom:675px;}
#t1j_42{left:279px;bottom:605px;letter-spacing:-0.13px;}
#t1k_42{left:303px;bottom:613px;}
#t1l_42{left:279px;bottom:566px;letter-spacing:-0.1px;}
#t1m_42{left:279px;bottom:527px;letter-spacing:-0.09px;}
#t1n_42{left:279px;bottom:509px;letter-spacing:-0.1px;}
#t1o_42{left:279px;bottom:491px;letter-spacing:-0.1px;}
#t1p_42{left:354px;bottom:498px;}
#t1q_42{left:366px;bottom:491px;letter-spacing:-0.09px;}
#t1r_42{left:279px;bottom:472px;letter-spacing:-0.09px;}
#t1s_42{left:279px;bottom:454px;letter-spacing:-0.09px;}
#t1t_42{left:547px;bottom:570px;letter-spacing:-0.09px;word-spacing:-0.39px;}
#t1u_42{left:547px;bottom:551px;letter-spacing:-0.09px;}
#t1v_42{left:547px;bottom:533px;letter-spacing:-0.09px;}
#t1w_42{left:612px;bottom:541px;}
#t1x_42{left:547px;bottom:425px;letter-spacing:-0.1px;}
#t1y_42{left:547px;bottom:407px;letter-spacing:-0.09px;}
#t1z_42{left:547px;bottom:388px;letter-spacing:-0.09px;}
#t20_42{left:612px;bottom:396px;}
#t21_42{left:700px;bottom:503px;letter-spacing:-0.09px;}
#t22_42{left:700px;bottom:485px;letter-spacing:-0.1px;}
#t23_42{left:700px;bottom:418px;letter-spacing:-0.08px;}
#t24_42{left:700px;bottom:400px;letter-spacing:-0.11px;}
#t25_42{left:700px;bottom:329px;letter-spacing:-0.08px;word-spacing:-0.2px;}
#t26_42{left:700px;bottom:310px;letter-spacing:-0.09px;}
#t27_42{left:832px;bottom:550px;letter-spacing:-0.1px;}
#t28_42{left:832px;bottom:504px;letter-spacing:-0.1px;}
#t29_42{left:832px;bottom:486px;letter-spacing:-0.13px;}
#t2a_42{left:855px;bottom:494px;letter-spacing:-0.09px;}
#t2b_42{left:879px;bottom:486px;letter-spacing:-0.09px;}
#t2c_42{left:832px;bottom:432px;letter-spacing:-0.02px;word-spacing:-0.06px;}
#t2d_42{left:832px;bottom:414px;letter-spacing:-0.09px;}
#t2e_42{left:832px;bottom:396px;letter-spacing:-0.06px;}
#t2f_42{left:832px;bottom:377px;letter-spacing:-0.13px;}
#t2g_42{left:855px;bottom:385px;}
#t2h_42{left:832px;bottom:320px;letter-spacing:-0.13px;}
#t2i_42{left:855px;bottom:327px;}
#t2j_42{left:1057px;bottom:483px;letter-spacing:-0.1px;}
#t2k_42{left:1057px;bottom:465px;letter-spacing:-0.09px;}
#t2l_42{left:1057px;bottom:446px;letter-spacing:-0.08px;}
#t2m_42{left:1064px;bottom:384px;letter-spacing:-0.26px;}
#t2n_42{left:1064px;bottom:365px;letter-spacing:-0.23px;}
#t2o_42{left:1064px;bottom:347px;letter-spacing:-0.25px;}
#t2p_42{left:1064px;bottom:329px;letter-spacing:-0.26px;}
#t2q_42{left:1064px;bottom:310px;letter-spacing:-0.42px;}
#t2r_42{left:547px;bottom:272px;letter-spacing:-0.09px;}
#t2s_42{left:547px;bottom:254px;letter-spacing:-0.08px;}
#t2t_42{left:547px;bottom:235px;letter-spacing:-0.09px;}
#t2u_42{left:832px;bottom:255px;letter-spacing:-0.11px;}
#t2v_42{left:932px;bottom:263px;}
#t2w_42{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_42{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_42{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_42{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_42{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_42{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_42{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_42{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_42{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s8_42{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s9_42{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sa_42{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sb_42{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts42" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg42Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg42" style="-webkit-user-select: none;"><object width="1210" height="935" data="42/42.svg" type="image/svg+xml" id="pdf42" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_42" class="t s0_42">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_42" class="t s1_42">® </span>
<span id="t3_42" class="t s0_42">(NCCN </span>
<span id="t4_42" class="t s1_42">® </span>
<span id="t5_42" class="t s0_42">), All rights reserved. NCCN Guidelines </span>
<span id="t6_42" class="t s1_42">® </span>
<span id="t7_42" class="t s0_42">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_42" class="t s2_42">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_42" class="t s2_42">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_42" class="t s3_42">NCCN Guidelines Version 4.2024 </span>
<span id="tb_42" class="t s3_42">Cancer of the Glottic Larynx </span>
<span id="tc_42" class="t s4_42">NCCN Guidelines Index </span>
<span id="td_42" class="t s4_42">Table of Contents </span>
<span id="te_42" class="t s4_42">Discussion </span>
<span id="tf_42" class="t s5_42">GLOT-2 </span>
<span id="tg_42" class="t s6_42">i </span>
<span id="th_42" class="t s7_42">Nodal disease in such glottic tumors is rare. </span><span id="ti_42" class="t s8_42">See Discussion</span><span id="tj_42" class="t s7_42">. </span>
<span id="tk_42" class="t s6_42">j </span>
<span id="tl_42" class="t s8_42">Principles of Radiation Therapy (GLOT-A)</span><span id="tm_42" class="t s7_42">. </span>
<span id="tn_42" class="t s6_42">k </span>
<span id="to_42" class="t s8_42">Principles of Surgery (SURG-A)</span><span id="tp_42" class="t s7_42">. </span>
<span id="tq_42" class="t s6_42">l </span>
<span id="tr_42" class="t s7_42">Adverse pathologic features: extranodal extension, positive margins, </span>
<span id="ts_42" class="t s7_42">close margins, pT4 primary, pN2 or pN3 nodal disease, perineural </span>
<span id="tt_42" class="t s7_42">invasion, vascular invasion, lymphatic invasion, and subglottic </span>
<span id="tu_42" class="t s7_42">extension </span><span id="tv_42" class="t s8_42">(Discussion)</span><span id="tw_42" class="t s7_42">. </span>
<span id="tx_42" class="t s6_42">m </span>
<span id="ty_42" class="t s8_42">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers </span>
<span id="tz_42" class="t s8_42">(SYST-A)</span><span id="t10_42" class="t s7_42">. </span>
<span id="t11_42" class="t s5_42">CLINICAL STAGING </span><span id="t12_42" class="t s5_42">TREATMENT OF PRIMARY AND NECK </span><span id="t13_42" class="t s5_42">ADJUVANT </span>
<span id="t14_42" class="t s5_42">TREATMENT </span>
<span id="t15_42" class="t s5_42">FOLLOW-UP </span>
<span id="t16_42" class="t s5_42">Carcinoma in situ </span>
<span id="t17_42" class="t s5_42">Amenable to </span>
<span id="t18_42" class="t s5_42">larynx- </span>
<span id="t19_42" class="t s5_42">preserving </span>
<span id="t1a_42" class="t s5_42">(conservation) </span>
<span id="t1b_42" class="t s5_42">surgery </span>
<span id="t1c_42" class="t s5_42">(T1–T2,N0 or </span>
<span id="t1d_42" class="t s5_42">select T3,N0) </span>
<span id="t1e_42" class="t s9_42">i </span>
<span id="t1f_42" class="t s5_42">Endoscopic resection (preferred) </span>
<span id="t1g_42" class="t s5_42">or </span>
<span id="t1h_42" class="t s5_42">RT </span>
<span id="t1i_42" class="t s9_42">j </span>
<span id="t1j_42" class="t s5_42">RT </span>
<span id="t1k_42" class="t s9_42">j </span>
<span id="t1l_42" class="t s5_42">or </span>
<span id="t1m_42" class="t s5_42">Partial laryngectomy/ </span>
<span id="t1n_42" class="t s5_42">endoscopic or open </span>
<span id="t1o_42" class="t s5_42">resection </span>
<span id="t1p_42" class="t s9_42">k </span>
<span id="t1q_42" class="t s5_42">as indicated </span>
<span id="t1r_42" class="t s5_42">and neck dissection as </span>
<span id="t1s_42" class="t s5_42">indicated </span>
<span id="t1t_42" class="t s5_42">No adverse </span>
<span id="t1u_42" class="t s5_42">pathologic </span>
<span id="t1v_42" class="t s5_42">features </span>
<span id="t1w_42" class="t s9_42">l </span>
<span id="t1x_42" class="t s5_42">Adverse </span>
<span id="t1y_42" class="t s5_42">pathologic </span>
<span id="t1z_42" class="t s5_42">features </span>
<span id="t20_42" class="t s9_42">l </span>
<span id="t21_42" class="t s5_42">Extranodal </span>
<span id="t22_42" class="t s5_42">extension </span>
<span id="t23_42" class="t s5_42">Positive </span>
<span id="t24_42" class="t s5_42">margin </span>
<span id="t25_42" class="t s5_42">Other risk </span>
<span id="t26_42" class="t s5_42">features </span>
<span id="t27_42" class="t s5_42">Observation </span>
<span id="t28_42" class="t s5_42">Systemic therapy/ </span>
<span id="t29_42" class="t s5_42">RT </span>
<span id="t2a_42" class="t s9_42">j,m </span>
<span id="t2b_42" class="t s5_42">(category 1) </span>
<span id="t2c_42" class="t s5_42">Re-resection, if </span>
<span id="t2d_42" class="t s5_42">feasible </span>
<span id="t2e_42" class="t s5_42">or </span>
<span id="t2f_42" class="t s5_42">RT </span>
<span id="t2g_42" class="t s9_42">j </span>
<span id="t2h_42" class="t s5_42">RT </span>
<span id="t2i_42" class="t s9_42">j </span>
<span id="t2j_42" class="t s5_42">Follow-up </span>
<span id="t2k_42" class="t sa_42">(FOLL-A, 1 </span>
<span id="t2l_42" class="t sa_42">of 2) </span>
<span id="t2m_42" class="t s5_42">Recurrent </span>
<span id="t2n_42" class="t s5_42">or </span>
<span id="t2o_42" class="t s5_42">persistent </span>
<span id="t2p_42" class="t s5_42">disease </span>
<span id="t2q_42" class="t sa_42">(ADV-3) </span>
<span id="t2r_42" class="t s5_42">pN1 without </span>
<span id="t2s_42" class="t s5_42">other risk </span>
<span id="t2t_42" class="t s5_42">features </span>
<span id="t2u_42" class="t s5_42">Consider RT </span>
<span id="t2v_42" class="t s9_42">j </span>
<span id="t2w_42" class="t sb_42">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
